Jeremy H. Tchaicha - Concepedia

Concepedia

Author

Jeremy H. Tchaicha

Dana-Farber Cancer Institute ORCID

Also Known As

J H Tchaicha, J. Tchaicha, Janne, Pasi A., Jeremy H. Tchaicha, Jeremy Hatem Tchaicha, Jeremy Tchaicha, Jeremy H. Tchaicha, Sivachenko, Andrey, Tchaicha, Jeremy H., Wang, Xiaoxu

162

Publications

4.3K

Citations

18

H-Index

30

Concepts

All Affiliations

Dana-Farber Cancer Institute Harvard University Brigham and Women's Hospital Broad Institute The University of Texas MD Anderson Cancer Center

JH

About

Jeremy H. Tchaicha is an author at Dana-Farber Cancer Institute specializing in tumor biology, cell biology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	1.6K
2	Cell Biology	8	8	1.6K
3	Pathology	3	3	583
4	Immunology	2	2	867
5	Health Sciences	1	1	69

Jeremy H. Tchaicha

×

18

Publications

4.3K

Citations

18

H-Index

	Year	Citations
Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors Esra A. Akbay, Shohei Koyama, Julián Carretero, Cancer Discovery	2013	1.2K
Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells Olivier De Henau, Matthew Rausch, David A. Winkler, Nature Hematological MalignancyBlockade TherapyImmunologyImmune Checkpoint InhibitorMyeloid Cells	2016	843
Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine Luís Felipe Campesato, Sadna Budhu, Jeremy H. Tchaicha, Nature Communications	2020	418
Loss of Lkb1 and Pten Leads to Lung Squamous Cell Carcinoma with Elevated PD-L1 Expression Chunxiao Xu, Christine M. Fillmore, Shohei Koyama, Cancer Cell Tumor BiologyPten LeadsMedicinePathologyBronchial Neoplasm	2014	378
Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer Giorgia Zadra, Caroline F. Ribeiro, Paolo Chetta, Proceedings of the National Academy of Sciences	2018	275
Efficacy of BET Bromodomain Inhibition in Kras-Mutant Non–Small Cell Lung Cancer Takeshi Shimamura, Zhao Chen, Margaret Soucheray, Clinical Cancer Research	2013	200
Inhibitor-Sensitive FGFR2 and FGFR3 Mutations in Lung Squamous Cell Carcinoma Rachel G. Liao, Joonil Jung, Jeremy H. Tchaicha, Cancer Research Family MembersFgfr InhibitorsMedicineInhibitor-sensitive Fgfr2Pathology	2013	167
Metabolic and Functional Genomic Studies Identify Deoxythymidylate Kinase as a Target in <i>LKB1</i> -Mutant Lung Cancer Yan Liu, Kevin Marks, Glenn S. Cowley, Cancer Discovery	2013	151
Glioblastoma Angiogenesis and Tumor Cell Invasiveness Are Differentially Regulated by β8 Integrin Jeremy H. Tchaicha, Steve B. Reyes, Jaekyung Shin, Cancer Research	2011	88
D-2-hydroxyglutarate produced by mutant IDH2 causes cardiomyopathy and neurodegeneration in mice Esra A. Akbay, Javid J. Moslehi, Camilla L. Christensen, Genes & Development	2014	86

Page 1